Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Black ginger (Kaempferia parviflora) has been investigated in several preclinical studies for its potential anticancer properties. Laboratory research has identified various bioactive compounds in black ginger, such as methoxyflavones, that exhibit antioxidant, anti-inflammatory, and antiproliferative effects. In vitro (test tube) studies have shown that extracts of black ginger can inhibit the growth of cancer cell lines such as prostate, colon, and breast cancer, possibly by inducing apoptosis (programmed cell death) and disrupting cancer cell signaling pathways. Additionally, some animal studies suggest that black ginger may reduce tumor growth, likely due to its antioxidant and anti-inflammatory properties. However, it is important to note that the current evidence is limited to laboratory and animal research; there are no robust clinical trials in humans that confirm its effectiveness for cancer prevention or treatment. As such, while there is scientific interest and some laboratory evidence supporting black ginger’s potential anticancer effects, the clinical relevance and safety for cancer prevention in humans remain unproven. Black ginger is not a substitute for standard cancer therapies. Further research, especially well-designed human studies, is needed to determine its true efficacy and safety profile in cancer prevention and treatment.

More about black ginger
More about Cancer (prevention)

Other ingredients used for Cancer (prevention)

Other health conditions supported by black ginger

Products containing black ginger